CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
271 hedge funds and large institutions have $4.57B invested in Clovis Oncology, Inc. in 2017 Q2 according to their latest regulatory filings, with 73 funds opening new positions, 109 increasing their positions, 72 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
51% more repeat investments, than reductions
Existing positions increased: 109 | Existing positions reduced: 72
18% more funds holding
Funds holding: 229 → 271 (+42)
Holders
271
Holding in Top 10
16
Calls
$300M
Puts
$156M
Top Buyers
| 1 | +$197M | |
| 2 | +$165M | |
| 3 | +$76.6M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$64.4M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$58.2M |
Top Sellers
| 1 | -$84.8M | |
| 2 | -$73.9M | |
| 3 | -$60.7M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$59.6M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$52.9M |